Transcranial Magnetic Stimulation
Offering a path to a better life | Over 2000 treatments given
TMS therapy has shown to be a safe, effective treatment option for many people suffering with a wide variety of conditions.
NeurOasis is the only licensed facility in Arizona for TMS therapy, and we now accept Medicare.
NeurOasis is currently treating Treatment-Resistant Major Depressive Disorder, Parkinson’s Disease related Depression, General Anxiety Disorder, Post Traumatic Stress Disorder, Migraine Headache, Neuropathic Pain and Fibromyalgia, and Smoking Cessation. We are working to add treatment of other disorders, such as tinnitus, autism spectrum disorders, and eating disorders.
Hear from a real NeurOasis patient about the difference TMS Therapy can make in your life.
Transcranial magnetic stimulation therapy is an innovative approach to managing symptoms of depression for anyone that has not adequately benefited from other treatment options.
Transcranial Magnetic Stimulation is a safe and effective non-drug treatment for patients who are not satisfied with the results of other treatment options.
f standard medications have not made a difference in your health, Transcranial Magnetic Stimulation may help you reduce your symptoms.
Yes. More than 25,000 patients have seen success from treatment with TMS Therapy, and it is free from common side effects associated with other standard medications.
Visit our Patient Corner to learn how this innovative approach has benefited real individuals like you.
Our goal is your progress.
Our providers and support staff are expertly trained to administer transcranial magnetic stimulation, and we will make your treatment as easy and as comfortable as possible.
Every aspect of your treatment at NeurOasis was designed with your maximum comfort in mind. We are here to help you find relief in a peaceful, caring environment.
TMS Therapy has helped reduce symptoms in thousands of people. We are eager to discuss whether or not this treatment is right for you, so that you might be among them.